Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ATP5MGP3 is a pseudogene related to the mitochondrial ATP synthase membrane subunit g (Fo complex), part of the enzyme complex that produces ATP using a transmembrane proton gradient during oxidative phosphorylation. ATP5MGP3 itself is non-protein-coding, and lacks known biological function, therapeutic targeting, disease association, or drug interaction. Its parent gene (ATP5MG) is a component of the mitochondrial ATP synthase, which is essential for energy production in cells[2][3].
None (no relevant mechanism of action, as ATP5MGP3 is not expressed as a protein)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP synthase membrane subunit g pseudogene 3 (ATP5MGP3).